{"transactions":[{"id":758927,"issuer":{"id":4958,"kind":"organization","name":"Immix Biopharma, Inc."},"owners":[{"id":43210,"kind":"person","name":"Morris Gabriel S","position":1,"cik":"0001889967","reported_name":"Morris Gabriel S","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO, President"}}],"security":"Stock Option (Right to Buy)","published_at":"2026-05-29T21:05:22.000Z","date":"2026-05-22","kind":"grant","planned":false,"acquired":true,"shares":500000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The Stock Option will vest in 48 equal monthly installments following the date of grant, subject to the Reporting Person's continued service with the Issuer."}],"balance_after":500000,"derivative":{"exercise_price":8.78,"expiration_date":"2036-05-22","underlying":"Common Stock","underlying_shares":500000},"source":{"system":"sec-edgar","filing":"0001493152-26-026428","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1889967/000149315226026428/ownership.xml","form_type":"4"}},{"id":974656,"issuer":{"id":4958,"kind":"organization","name":"Immix Biopharma, Inc."},"owners":[{"id":43210,"kind":"person","name":"Morris Gabriel S","position":1,"cik":"0001889967","reported_name":"Morris Gabriel S","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO"}}],"security":"Warrants (right to purchase)","published_at":"2025-12-10T23:47:20.000Z","date":"2025-12-08","kind":"other","planned":false,"acquired":false,"shares":60000,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"Gabriel Morris is the Managing Partner and Sole Member of Alwaysraise LLC (\"Alwaysraise\") and in such capacity has the right to vote and dispose of the securities held by such entity. Mr. Morris disclaims beneficial ownership of the securities reported herein as held by Alwaysraise, except to the extent of his pecuniary interest therein."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"The warrants were held by Alwaysraise LLC."}],"balance_after":0,"derivative":{"exercise_price":0.8,"exercise_date":"2021-04-02","expiration_date":"2031-04-02","underlying":"Common stock","underlying_shares":60000},"source":{"system":"sec-edgar","filing":"0001493152-25-027107","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1889967/000149315225027107/ownership.xml","form_type":"4"}},{"id":974655,"issuer":{"id":4958,"kind":"organization","name":"Immix Biopharma, Inc."},"owners":[{"id":43210,"kind":"person","name":"Morris Gabriel S","position":1,"cik":"0001889967","reported_name":"Morris Gabriel S","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO"}}],"security":"Warrants (right to purchase)","published_at":"2025-12-10T23:47:20.000Z","date":"2025-12-08","kind":"other","planned":false,"acquired":false,"shares":96000,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"Gabriel Morris is the Managing Partner and Sole Member of Alwaysraise LLC (\"Alwaysraise\") and in such capacity has the right to vote and dispose of the securities held by such entity. Mr. Morris disclaims beneficial ownership of the securities reported herein as held by Alwaysraise, except to the extent of his pecuniary interest therein."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"The warrants were held by Alwaysraise LLC."}],"balance_after":0,"derivative":{"exercise_price":0.8,"exercise_date":"2021-03-18","expiration_date":"2031-03-18","underlying":"Common stock","underlying_shares":96000},"source":{"system":"sec-edgar","filing":"0001493152-25-027107","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1889967/000149315225027107/ownership.xml","form_type":"4"}},{"id":974654,"issuer":{"id":4958,"kind":"organization","name":"Immix Biopharma, Inc."},"owners":[{"id":43210,"kind":"person","name":"Morris Gabriel S","position":1,"cik":"0001889967","reported_name":"Morris Gabriel S","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO"}}],"security":"Common Stock","published_at":"2025-12-10T23:47:20.000Z","date":"2025-12-10","kind":"purchase","planned":false,"acquired":true,"shares":770,"price":6.58,"value":5066.6,"ownership":{"direct":true},"balance_after":291429,"source":{"system":"sec-edgar","filing":"0001493152-25-027107","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1889967/000149315225027107/ownership.xml","form_type":"4"}},{"id":974653,"issuer":{"id":4958,"kind":"organization","name":"Immix Biopharma, Inc."},"owners":[{"id":43210,"kind":"person","name":"Morris Gabriel S","position":1,"cik":"0001889967","reported_name":"Morris Gabriel S","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO"}}],"security":"Common Stock","published_at":"2025-12-10T23:47:20.000Z","date":"2025-12-08","kind":"other","planned":false,"acquired":true,"shares":156000,"price":0.8,"value":124800.0,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"Gabriel Morris is the Managing Partner and Sole Member of Alwaysraise LLC (\"Alwaysraise\") and in such capacity has the right to vote and dispose of the securities held by such entity. Mr. Morris disclaims beneficial ownership of the securities reported herein as held by Alwaysraise, except to the extent of his pecuniary interest therein."}],"balance_after":426844,"source":{"system":"sec-edgar","filing":"0001493152-25-027107","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1889967/000149315225027107/ownership.xml","form_type":"4"}},{"id":1038066,"issuer":{"id":4958,"kind":"organization","name":"Immix Biopharma, Inc."},"owners":[{"id":43210,"kind":"person","name":"Morris Gabriel S","position":1,"cik":"0001889967","reported_name":"Morris Gabriel S","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO"}}],"security":"Common Stock","published_at":"2025-09-17T21:20:32.000Z","date":"2025-09-16","kind":"purchase","planned":false,"acquired":true,"shares":2600,"price":1.97,"value":5122.0,"ownership":{"direct":true},"balance_after":290659,"source":{"system":"sec-edgar","filing":"0001493152-25-013918","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1889967/000149315225013918/ownership.xml","form_type":"4"}},{"id":1103993,"issuer":{"id":4958,"kind":"organization","name":"Immix Biopharma, Inc."},"owners":[{"id":43210,"kind":"person","name":"Morris Gabriel S","position":1,"cik":"0001889967","reported_name":"Morris Gabriel S","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO"}}],"security":"Stock Option (Right to Buy)","published_at":"2025-06-23T20:57:38.000Z","date":"2025-06-20","kind":"grant","planned":false,"acquired":true,"shares":340000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The Stock Option will vest in forty-eight (48) equal monthly installments following the date of grant, subject to the Reporting Person's continued service with the Issuer."}],"balance_after":340000,"derivative":{"exercise_price":2.24,"expiration_date":"2035-06-20","underlying":"Common Stock","underlying_shares":340000},"source":{"system":"sec-edgar","filing":"0001641172-25-016114","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1889967/000164117225016114/ownership.xml","form_type":"4"}},{"id":1105168,"issuer":{"id":4958,"kind":"organization","name":"Immix Biopharma, Inc."},"owners":[{"id":43210,"kind":"person","name":"Morris Gabriel S","position":1,"cik":"0001889967","reported_name":"Morris Gabriel S","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO"}}],"security":"Common Stock","published_at":"2025-06-20T13:35:31.000Z","date":"2025-06-18","kind":"purchase","planned":false,"acquired":true,"shares":2225,"price":2.279,"value":5070.775,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Volume-weighted average price. The Reporting Person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer, full information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":288059,"source":{"system":"sec-edgar","filing":"0001641172-25-015755","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1889967/000164117225015755/ownership.xml","form_type":"4"}},{"id":1472261,"issuer":{"id":4958,"kind":"organization","name":"Immix Biopharma, Inc."},"owners":[{"id":43210,"kind":"person","name":"Morris Gabriel S","position":1,"cik":"0001889967","reported_name":"Morris Gabriel S","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO"}}],"security":"Stock Option (Right to Buy)","published_at":"2024-06-21T21:45:10.000Z","date":"2024-06-11","kind":"grant","planned":false,"acquired":true,"shares":340000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The Stock Option will vest in 48 equal monthly installments following the date of grant, subject to the Reporting Person's continued service with the Issuer."}],"balance_after":340000,"derivative":{"exercise_price":2.04,"expiration_date":"2034-06-11","underlying":"Common Stock","underlying_shares":340000},"source":{"system":"sec-edgar","filing":"0001493152-24-024826","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1889967/000149315224024826/ownership.xml","form_type":"4"}},{"id":1485211,"issuer":{"id":4958,"kind":"organization","name":"Immix Biopharma, Inc."},"owners":[{"id":43210,"kind":"person","name":"Morris Gabriel S","position":1,"cik":"0001889967","reported_name":"Morris Gabriel S","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO"}}],"security":"Common Stock","published_at":"2024-06-10T13:00:16.000Z","date":"2024-06-07","kind":"purchase","planned":false,"acquired":true,"shares":2500,"price":2.1192,"value":5298.0,"ownership":{"direct":true},"balance_after":285834,"source":{"system":"sec-edgar","filing":"0001493152-24-023288","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1889967/000149315224023288/ownership.xml","form_type":"4"}},{"id":1490345,"issuer":{"id":4958,"kind":"organization","name":"Immix Biopharma, Inc."},"owners":[{"id":43210,"kind":"person","name":"Morris Gabriel S","position":1,"cik":"0001889967","reported_name":"Morris Gabriel S","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO"}}],"security":"Common Stock","published_at":"2024-06-05T13:00:26.000Z","date":"2024-06-04","kind":"purchase","planned":false,"acquired":true,"shares":3300,"price":1.8099,"value":5972.67,"ownership":{"direct":true},"balance_after":283334,"source":{"system":"sec-edgar","filing":"0001493152-24-022654","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1889967/000149315224022654/ownership.xml","form_type":"4"}},{"id":1509200,"issuer":{"id":4958,"kind":"organization","name":"Immix Biopharma, Inc."},"owners":[{"id":43210,"kind":"person","name":"Morris Gabriel S","position":1,"cik":"0001889967","reported_name":"Morris Gabriel S","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO"}}],"security":"Common Stock","published_at":"2024-05-20T21:25:35.000Z","date":"2024-05-20","kind":"grant","planned":false,"acquired":true,"shares":24141,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Received in exchange for shares of common stock of Nexcella, Inc. which were held by the Reporting Person, which entity was merged with and into the Issuer on May 20, 2024, with the Issuer continuing as the surviving entity."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"Gabriel Morris is the Managing Partner of Alwaysraise Ventures I Investments, LLC (\"Alwaysraise Ventures\"), the general partner of Alwaysraise Ventures I, LP. (\"AVILP\") and in such capacity has the right to vote and dispose of the securities held by such entity. Mr. Morris disclaims beneficial ownership of the securities reported herein as held by AVILP, except to the extent of his pecuniary interest therein."}],"balance_after":24141,"source":{"system":"sec-edgar","filing":"0001493152-24-020776","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1889967/000149315224020776/ownership.xml","form_type":"4"}},{"id":1509199,"issuer":{"id":4958,"kind":"organization","name":"Immix Biopharma, Inc."},"owners":[{"id":43210,"kind":"person","name":"Morris Gabriel S","position":1,"cik":"0001889967","reported_name":"Morris Gabriel S","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO"}}],"security":"Common Stock","published_at":"2024-05-20T21:25:35.000Z","date":"2024-05-20","kind":"grant","planned":false,"acquired":true,"shares":24141,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Received in exchange for shares of common stock of Nexcella, Inc. which were held by the Reporting Person, which entity was merged with and into the Issuer on May 20, 2024, with the Issuer continuing as the surviving entity."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Gabriel Morris is the Managing Partner and Sole Member of Alwaysraise LLC (\"Alwaysraise\") and in such capacity has the right to vote and dispose of the securities held by such entity. Mr. Morris disclaims beneficial ownership of the securities reported herein as held by Alwaysraise, except to the extent of his pecuniary interest therein."}],"balance_after":270844,"source":{"system":"sec-edgar","filing":"0001493152-24-020776","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1889967/000149315224020776/ownership.xml","form_type":"4"}},{"id":1509198,"issuer":{"id":4958,"kind":"organization","name":"Immix Biopharma, Inc."},"owners":[{"id":43210,"kind":"person","name":"Morris Gabriel S","position":1,"cik":"0001889967","reported_name":"Morris Gabriel S","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO"}}],"security":"Common Stock","published_at":"2024-05-20T21:25:35.000Z","date":"2024-05-20","kind":"grant","planned":false,"acquired":true,"shares":194218,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Received in exchange for shares of common stock of Nexcella, Inc. which were held by the Reporting Person, which entity was merged with and into the Issuer on May 20, 2024, with the Issuer continuing as the surviving entity."}],"balance_after":280034,"source":{"system":"sec-edgar","filing":"0001493152-24-020776","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1889967/000149315224020776/ownership.xml","form_type":"4"}},{"id":1517744,"issuer":{"id":4958,"kind":"organization","name":"Immix Biopharma, Inc."},"owners":[{"id":43210,"kind":"person","name":"Morris Gabriel S","position":1,"cik":"0001889967","reported_name":"Morris Gabriel S","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO"}}],"security":"Common Stock","published_at":"2024-05-15T01:29:40.000Z","date":"2024-05-14","kind":"purchase","planned":false,"acquired":true,"shares":4500,"price":2.2315,"value":10041.75,"ownership":{"direct":true},"balance_after":85816,"source":{"system":"sec-edgar","filing":"0001493152-24-019368","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1889967/000149315224019368/ownership.xml","form_type":"4"}},{"id":1745889,"issuer":{"id":4958,"kind":"organization","name":"Immix Biopharma, Inc."},"owners":[{"id":43210,"kind":"person","name":"Morris Gabriel S","position":1,"cik":"0001889967","reported_name":"Morris Gabriel S","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO"}}],"security":"Stock Options","published_at":"2023-11-10T00:57:06.000Z","date":"2023-08-14","kind":"grant","planned":false,"acquired":true,"shares":293000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Options vest monthly over 48 months from the date of grant."}],"balance_after":293000,"derivative":{"exercise_price":1.86,"expiration_date":"2033-08-14","underlying":"Common Stock","underlying_shares":293000},"source":{"system":"sec-edgar","filing":"0001493152-23-040177","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1889967/000149315223040177/ownership.xml","form_type":"4/A","original_submission_date":"2023-08-14"}},{"id":1808775,"issuer":{"id":4958,"kind":"organization","name":"Immix Biopharma, Inc."},"owners":[{"id":43210,"kind":"person","name":"Morris Gabriel S","position":1,"cik":"0001889967","reported_name":"Morris Gabriel S","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO"}}],"security":"Stock Options","published_at":"2023-08-14T20:15:45.000Z","date":"2023-08-11","kind":"grant","planned":false,"acquired":true,"shares":193000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Options vest monthly over 48 months from the date of grant."}],"balance_after":193000,"derivative":{"exercise_price":1.86,"expiration_date":"2033-08-11","underlying":"Common Stock","underlying_shares":193000},"source":{"system":"sec-edgar","filing":"0001493152-23-028477","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1889967/000149315223028477/ownership.xml","form_type":"4"}},{"id":2116457,"issuer":{"id":4958,"kind":"organization","name":"Immix Biopharma, Inc."},"owners":[{"id":43210,"kind":"person","name":"Morris Gabriel S","position":1,"cik":"0001889967","reported_name":"Morris Gabriel S","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO"}}],"security":"Common Stock","published_at":"2022-11-15T22:31:08.000Z","date":"2022-11-14","kind":"purchase","acquired":true,"shares":5200,"price":0.94,"value":4888.0,"ownership":{"direct":true},"balance_after":81316,"source":{"system":"sec-edgar","filing":"0001493152-22-032555","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1889967/000149315222032555/ownership.xml","form_type":"4"}},{"id":2206372,"issuer":{"id":4958,"kind":"organization","name":"Immix Biopharma, Inc."},"owners":[{"id":43210,"kind":"person","name":"Morris Gabriel S","position":1,"cik":"0001889967","reported_name":"Morris Gabriel S","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO"}}],"security":"Stock Options","published_at":"2022-07-18T10:02:25.000Z","date":"2022-07-14","kind":"grant","acquired":true,"shares":250000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Options vest monthly in equal amounts over 48 months."}],"balance_after":716500,"derivative":{"exercise_price":2.64,"expiration_date":"2032-07-14","underlying":"Common Stock","underlying_shares":250000},"source":{"system":"sec-edgar","filing":"0001493152-22-019497","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1889967/000149315222019497/ownership.xml","form_type":"4"}},{"id":2464186,"issuer":{"id":4958,"kind":"organization","name":"Immix Biopharma, Inc."},"owners":[{"id":43210,"kind":"person","name":"Morris Gabriel S","position":1,"cik":"0001889967","reported_name":"Morris Gabriel S","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Convertible Note","published_at":"2021-12-20T21:15:18.000Z","date":"2021-12-20","kind":"exercise","acquired":false,"price":0,"reported_value":100000,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"On April 2, 2021, the Registrant issued Alwaysraise a note in the amount of $100,000 which is payable upon request of the majority holders of like tenure notes on or after March 1, 2023. Pursuant to the terms of the note, because the Registrant sold equity securities in its initial public offering resulting in proceeds of at least $10 million, the note automatically converted into shares of the Registrant's common stock."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"On April 2, 2021, the Registrant issued Alwaysraise a note in the amount of $100,000 which is payable upon request of the majority holders of like tenure notes on or after March 1, 2023. Pursuant to the terms of the note, because the Registrant sold equity securities in its initial public offering resulting in proceeds of at least $10 million, the note automatically converted into shares of the Registrant's common stock."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"Gabriel Morris is the Managing Partner and Sole Member of Alwaysraise LLC (\"Alwaysraise\") and in such capacity has the right to vote and dispose of the securities held by such entity."}],"balance_after":0,"derivative":{"exercise_price":0.85,"underlying":"Common stock","underlying_shares":123176},"source":{"system":"sec-edgar","filing":"0001493152-21-032035","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1889967/000149315221032035/ownership.xml","form_type":"4"}},{"id":2464185,"issuer":{"id":4958,"kind":"organization","name":"Immix Biopharma, Inc."},"owners":[{"id":43210,"kind":"person","name":"Morris Gabriel S","position":1,"cik":"0001889967","reported_name":"Morris Gabriel S","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Convertible Note","published_at":"2021-12-20T21:15:18.000Z","date":"2021-12-20","kind":"exercise","acquired":false,"price":0,"reported_value":100000,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"On March 18, 2021, the Registrant issued Alwaysraise LLC a note in the amount of $100,000 which is payable upon request of the majority holders of like tenure notes on or after March 1, 2023. Pursuant to the terms of the note, because the Registrant sold equity securities in its initial public offering resulting in proceeds of at least $10 million, the note automatically converted into shares of the Registrant's common stock."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"On March 18, 2021, the Registrant issued Alwaysraise LLC a note in the amount of $100,000 which is payable upon request of the majority holders of like tenure notes on or after March 1, 2023. Pursuant to the terms of the note, because the Registrant sold equity securities in its initial public offering resulting in proceeds of at least $10 million, the note automatically converted into shares of the Registrant's common stock."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"Gabriel Morris is the Managing Partner and Sole Member of Alwaysraise LLC (\"Alwaysraise\") and in such capacity has the right to vote and dispose of the securities held by such entity."}],"balance_after":0,"derivative":{"exercise_price":0.85,"underlying":"Common stock","underlying_shares":123527},"source":{"system":"sec-edgar","filing":"0001493152-21-032035","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1889967/000149315221032035/ownership.xml","form_type":"4"}},{"id":2464184,"issuer":{"id":4958,"kind":"organization","name":"Immix Biopharma, Inc."},"owners":[{"id":43210,"kind":"person","name":"Morris Gabriel S","position":1,"cik":"0001889967","reported_name":"Morris Gabriel S","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Convertible Note","published_at":"2021-12-20T21:15:18.000Z","date":"2021-12-20","kind":"exercise","acquired":false,"price":0,"reported_value":60000,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"On March 18, 2021, the Registrant issued the Reporting Person a note in the amount of $60,000 which is payable upon request of the majority holders of like tenure notes on or after March 1, 2023. Pursuant to the terms of the note, because the Registrant sold equity securities in its initial public offering resulting in proceeds of at least $10 million, the note automatically converted into shares of the Registrant's common stock."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"On March 18, 2021, the Registrant issued the Reporting Person a note in the amount of $60,000 which is payable upon request of the majority holders of like tenure notes on or after March 1, 2023. Pursuant to the terms of the note, because the Registrant sold equity securities in its initial public offering resulting in proceeds of at least $10 million, the note automatically converted into shares of the Registrant's common stock."}],"balance_after":0,"derivative":{"exercise_price":0.85,"underlying":"Common stock","underlying_shares":74116},"source":{"system":"sec-edgar","filing":"0001493152-21-032035","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1889967/000149315221032035/ownership.xml","form_type":"4"}},{"id":2464183,"issuer":{"id":4958,"kind":"organization","name":"Immix Biopharma, Inc."},"owners":[{"id":43210,"kind":"person","name":"Morris Gabriel S","position":1,"cik":"0001889967","reported_name":"Morris Gabriel S","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2021-12-20T21:15:18.000Z","date":"2021-12-20","kind":"purchase","acquired":true,"shares":2000,"price":5,"value":10000.0,"ownership":{"direct":true},"balance_after":76116,"source":{"system":"sec-edgar","filing":"0001493152-21-032035","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1889967/000149315221032035/ownership.xml","form_type":"4"}},{"id":2464182,"issuer":{"id":4958,"kind":"organization","name":"Immix Biopharma, Inc."},"owners":[{"id":43210,"kind":"person","name":"Morris Gabriel S","position":1,"cik":"0001889967","reported_name":"Morris Gabriel S","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2021-12-20T21:15:18.000Z","date":"2021-12-20","kind":"exercise","acquired":true,"shares":123176,"price":0.85,"value":104699.6,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"Gabriel Morris is the Managing Partner and Sole Member of Alwaysraise LLC (\"Alwaysraise\") and in such capacity has the right to vote and dispose of the securities held by such entity."}],"balance_after":246703,"source":{"system":"sec-edgar","filing":"0001493152-21-032035","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1889967/000149315221032035/ownership.xml","form_type":"4"}},{"id":2464181,"issuer":{"id":4958,"kind":"organization","name":"Immix Biopharma, Inc."},"owners":[{"id":43210,"kind":"person","name":"Morris Gabriel S","position":1,"cik":"0001889967","reported_name":"Morris Gabriel S","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2021-12-20T21:15:18.000Z","date":"2021-12-20","kind":"exercise","acquired":true,"shares":123527,"price":0.85,"value":104997.95,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"Gabriel Morris is the Managing Partner and Sole Member of Alwaysraise LLC (\"Alwaysraise\") and in such capacity has the right to vote and dispose of the securities held by such entity."}],"balance_after":123527,"source":{"system":"sec-edgar","filing":"0001493152-21-032035","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1889967/000149315221032035/ownership.xml","form_type":"4"}},{"id":2464180,"issuer":{"id":4958,"kind":"organization","name":"Immix Biopharma, Inc."},"owners":[{"id":43210,"kind":"person","name":"Morris Gabriel S","position":1,"cik":"0001889967","reported_name":"Morris Gabriel S","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2021-12-20T21:15:18.000Z","date":"2021-12-20","kind":"exercise","acquired":true,"shares":74116,"price":0.85,"value":62998.6,"ownership":{"direct":true},"balance_after":74116,"source":{"system":"sec-edgar","filing":"0001493152-21-032035","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1889967/000149315221032035/ownership.xml","form_type":"4"}}]}